Table 1 Characteristics of the study participants.
Anthropometric and muscle strength | Men (n = 1564) | Women (n = 2125) | Overall (n = 3689) | P for sex |
|---|---|---|---|---|
Mean ± SD | Mean ± SD | Mean ± SD | ||
Age (years) | 69.8 ± 7.1 | 69.1 ± 6.9 | 69.4 ± 7.1 | 0.003 |
Height (cm) | 1.63 ± 0.1 | 1.50 ± 0.1 | 1.56 ± 0.1 | < 0.001 |
Body mass (kg) | 68.1 ± 12.2 | 62.9 ± 12.6 | 65.1 ± 12.7 | < 0.001 |
Calf circumference (cm) | 34.7 ± 3.4 | 34.6 ± 3.9 | 34.2 ± 3.7 | < 0.001 |
BMI (kg/m2) | 26.1 ± 4.1 | 28.2 ± 5.3 | 27.3 ± 4.9 | < 0.001 |
STS time (s) | 14.3 ± 4.1 | 15.6 ± 4.3 | 15.1 ± 4.2 | < 0.001 |
STS power (W·kg−1) | 2.2 ± 0.7 | 1.6 ± 0.5 | 1.9 ± 0.6 | < 0.001 |
Handgrip strength (kg/body mass) | 0.44 ± 0.1 | 0.28 ± 0.1 | 0.33 ± 0.1 | < 0.001 |
Gait speed (m/s) | 0.83 ± 0.27 | 0.73 ± 0.23 | 0.77 ± 0.25 | < 0.001 |
Sociodemographic and lifestyle outcomes | n (%) | n (%) | n (%) | |
|---|---|---|---|---|
Socio-economic status | ||||
Level I–II | 1252 (80.1) | 1614 (76) | 2866 (77.7) | < 0.001 |
Level III–IV | 307 (19.6) | 488 (23) | 795 (21.6) | < 0.001 |
Level V–VI | 5 (0.3) | 23 (1.1) | 28 (0.8) | 0.001 |
Urbanicity | ||||
Urban | 1129 (72.2) | 1686 (79.3) | 2815 (76.3) | < 0.001 |
Rural | 435 (27.8) | 439 (20.7) | 874 (23.7) | 0.892 |
Ethnic group | ||||
Indigenous | 130 (9.3) | 94 (5.1) | 224 (6.1) | 0.016 |
Black 'mulato' or Afro-Colombian | 158 (11.2) | 166 (9.0) | 324 (8.8) | 0.657 |
White | 408 (29) | 635 (34.4) | 1043 (28.3) | < 0.001 |
Othersa | 709 (50.5) | 953 (51.6) | 1662 (45.1) | < 0.001 |
Lifestyle | ||||
Alcohol | 382 (24.4) | 116 (5.5) | 498 (13.5) | < 0.001 |
Smoking | 234 (15.0) | 156 (7.3) | 390 (10.6) | < 0.001 |
Meeting PA recommendations | 388 (24.8) | 323 (15.2) | 711 (19.3) | 0.015 |
Neuromuscular disorders | ||||
Sarcopenia | 170 (11.0) | 331 (15.7) | 501 (13.6) | < 0.001 |
Dynapenia | 642 (41.8) | 997 (46.9) | 1619 (43.9) | < 0.001 |
Poor gait speed | 894 (58.9) | 1488 (74.1) | 2382 (64.6) | < 0.001 |
Neurocognitive disorders | ||||
Cognitive impairment | 159 (10.2) | 277 (13) | 436 (11.8) | < 0.001 |
Mental problems | 91 (5.8) | 215 (10.1) | 306 (8.3) | < 0.001 |
Visual problems | 892 (63.5) | 1222 (66.3) | 2114 (57.3) | < 0.001 |
Hearing problems | 428 (27.4) | 437 (20.6) | 865 (23.4) | 0.760 |
Memory | 216 (13.8) | 256 (12.0) | 472 (12.8) | < 0.001 |
Dementia | 77 (4.9) | 168 (7.9) | 245 (6.6) | < 0.001 |
Metabolic disorders | ||||
Hypertension | 714 (45.8) | 1254 (59.1) | 1968 (53.3) | < 0.001 |
Diabetes | 219 (14.0) | 371 (17.5) | 590 (16.0) | < 0.001 |
Cardiovascular diseases | 189 (12.1) | 289 (13.6) | 478 (13.0) | < 0.001 |
Other adverse events | ||||
Falls in the last year | 363 (23.2) | 728 (34.3) | 1091 (29.6) | < 0.001 |
Hospitalized > 24 h last year | 154 (9.8) | 243 (11.4) | 397 (10.8) | < 0.001 |